ArticleHaematologica2011

Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoids.

Joseph Pidala et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.